Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $1.77 Million - $3.46 Million
26,000 Added 185.71%
40,000 $2.98 Million
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $517,440 - $716,099
5,500 Added 64.71%
14,000 $7.16 Million
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $324,675 - $407,050
2,500 Added 41.67%
8,500 $4.56 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $640,260 - $859,080
6,000 New
6,000 $3.28 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.